## Overview
Hearing loss refers to a partial or complete inability to perceive sounds in one or both ears. It is classified by the World Health Organization (WHO) as disabling when the better-hearing ear has a pure-tone average threshold greater than 35 dB in adults. Hearing loss may develop gradually over years or strike suddenly within hours, and it can be temporary or permanent depending on the underlying cause.
Hearing loss is remarkably common. The WHO estimates that over 1.5 billion people worldwide live with some degree of hearing loss, and approximately 430 million have disabling hearing loss [1]. In the United States alone, roughly 15% of adults aged 18 and over report some trouble hearing, and the prevalence rises sharply with age — affecting nearly two-thirds of adults over 70 [2]. These figures make hearing loss one of the most common sensory deficits globally.
People search for information about hearing loss because the symptom is often distressing, socially isolating, and can signal a wide range of conditions — from benign earwax impaction to serious neurological disease. Research has also demonstrated that untreated hearing loss is independently associated with cognitive decline, depression, social withdrawal, and increased fall risk [3]. Understanding the causes, knowing when to seek help, and learning about available treatments are therefore critical for both quality of life and long-term health.
Hearing loss is broadly classified into three types:
- **Conductive hearing loss** — caused by problems in the outer or middle ear that block sound transmission
- **Sensorineural hearing loss (SNHL)** — caused by damage to the inner ear (cochlea) or auditory nerve
- **Mixed hearing loss** — a combination of both conductive and sensorineural components
The ICD-10 code H90 encompasses conductive and sensorineural hearing loss, with sub-codes specifying laterality and type.
## Common Causes
Hearing loss has numerous potential causes. Below are the most common, organized by mechanism and approximate frequency in clinical practice.
### 1. Age-Related Hearing Loss (Presbycusis)
Presbyacusis is the most common cause of hearing loss in adults and results from cumulative degeneration of cochlear hair cells, stria vascularis, and auditory neurons over decades. It typically presents as bilateral, symmetric, high-frequency sensorineural hearing loss that gradually worsens. A landmark review in *The Lancet* described presbycusis as affecting roughly one-third of adults over age 65 [4]. Genetic susceptibility, oxidative stress, and vascular insufficiency to the cochlea all contribute.
### 2. Noise-Induced Hearing Loss (NIHL)
Prolonged or acute exposure to loud sound damages the delicate stereocilia on cochlear outer hair cells. Occupational noise, recreational firearms use, loud music, and power tools are common culprits. NIHL typically produces a characteristic "4 kHz notch" on audiometry. The National Institute for Occupational Safety and Health (NIOSH) recommends limiting exposure to 85 dB for no more than 8 hours. NIHL is largely preventable but irreversible once established [2].
### 3. Cerumen (Earwax) Impaction
Excessive or impacted cerumen is the most common cause of reversible conductive hearing loss. It physically blocks the ear canal, preventing sound waves from reaching the tympanic membrane. It is estimated to affect 6% of the general population and up to 57% of nursing home residents.
### 4. Otitis Media (Middle Ear Infection/Effusion)
Acute otitis media and otitis media with effusion cause conductive hearing loss by filling the middle ear space with fluid or pus, which dampens tympanic membrane vibration and ossicular chain movement. This is particularly common in children but also affects adults, especially those with eustachian tube dysfunction [5].
### 5. Otosclerosis
Otosclerosis involves abnormal bone remodeling around the stapes footplate, progressively fixing it in the oval window and impairing sound conduction. It is the most common cause of conductive hearing loss in young adults, with onset typically in the 20s–40s. There is a strong genetic component, and the condition is more common in women, sometimes worsening during pregnancy.
### 6. Ototoxic Medications
Numerous medications can damage the cochlea or auditory nerve. The most well-known ototoxic agents include aminoglycoside antibiotics (gentamicin, tobramycin), loop diuretics (furosemide), platinum-based chemotherapy agents (cisplatin), high-dose aspirin, and quinine. The hearing loss is usually sensorineural and may be dose-dependent or idiosyncratic [2].
### 7. Ménière's Disease
Ménière's disease is an inner-ear disorder characterized by episodic vertigo, fluctuating low-frequency sensorineural hearing loss, tinnitus, and aural fullness. It is thought to result from endolymphatic hydrops — excess fluid accumulation in the inner ear. Over time, hearing loss may become permanent.
### 8. Sudden Sensorineural Hearing Loss (SSNHL)
SSNHL is defined as a rapid-onset hearing loss of at least 30 dB across three consecutive frequencies occurring within 72 hours. It affects 5–27 per 100,000 people annually and is considered an otologic emergency. In most cases the cause is idiopathic, though viral infection, vascular events, and autoimmune inner ear disease are suspected mechanisms [6].
### 9. Acoustic Neuroma (Vestibular Schwannoma)
This benign tumor arises from Schwann cells of the vestibulocochlear nerve (CN VIII). It typically presents with unilateral sensorineural hearing loss, tinnitus, and balance difficulty. Although rare, it must be excluded in any patient with asymmetric hearing loss.
### 10. Trauma
Temporal bone fractures, tympanic membrane perforation (from blast injuries, foreign objects, or barotrauma), and ossicular chain disruption can all cause acute hearing loss — conductive, sensorineural, or mixed depending on the structures involved.
## RED FLAGS
The following signs and symptoms associated with hearing loss warrant **immediate medical attention** (same-day evaluation or emergency department visit):
- **Sudden hearing loss in one or both ears** developing over minutes to hours — this is an otologic emergency; delay in treatment may result in permanent loss [6]
- **Hearing loss with severe headache, visual changes, or altered consciousness** — may indicate stroke, intracranial hemorrhage, or meningitis
- **Hearing loss with high fever and neck stiffness** — raises concern for bacterial meningitis
- **Hearing loss following head trauma** — possible temporal bone fracture or intracranial injury
- **Hearing loss with facial weakness or paralysis on the same side** — suggests facial nerve involvement (e.g., cholesteatoma, skull base pathology)
- **Rapidly progressive hearing loss over days to weeks** — may indicate autoimmune inner ear disease, infection, or neoplasm
- **Hearing loss with bloody or clear fluid draining from the ear** — possible CSF otorrhea or tympanic membrane perforation with infection
- **Hearing loss with new-onset severe vertigo, nausea, and inability to walk** — may signify labyrinthitis, cerebellar stroke, or other central pathology
- **Pulsatile tinnitus with hearing loss** — may indicate a vascular abnormality (glomus tumor, arteriovenous malformation, or carotid dissection)
> **Important:** Sudden sensorineural hearing loss should be treated as urgently as sudden vision loss. Guidelines recommend initiating corticosteroid therapy within 2 weeks of onset, but outcomes are best when treatment begins within 72 hours [6].
## Self-Care at Home
Several evidence-based, non-pharmacological measures may help manage or prevent hearing loss:
### Hearing Protection
- Use properly fitted earplugs or earmuffs in noisy environments (concerts, power tools, firearms). Foam earplugs, when correctly inserted, can reduce noise exposure by 20–30 dB.
- Follow the 60/60 rule for personal audio devices: listen at no more than 60% maximum volume for no more than 60 minutes at a time.
### Cerumen Management
- For mild wax buildup, over-the-counter cerumenolytic drops (e.g., mineral oil, glycerin, hydrogen peroxide–based solutions) applied 2–3 drops per ear for 3–5 days may soften and facilitate natural wax expulsion.
- **Do not insert cotton swabs, bobby pins, or any objects into the ear canal** — this can push wax deeper and risk tympanic membrane perforation.
- Gentle irrigation with body-temperature water using a bulb syringe may help after softening, but should be avoided if there is a known tympanic membrane perforation or ear tube.
### Communication Strategies
- Face the speaker directly in well-lit environments to facilitate lip-reading.
- Reduce background noise (turn off televisions, move to quieter rooms).
- Use assistive listening devices such as amplified telephones, TV hearing amplifiers, or smartphone captioning apps.
### Lifestyle Modifications
- **Cardiovascular health:** Maintain healthy blood pressure, cholesterol, and blood sugar levels. A 2020 Lancet Commission report identified hearing loss as the single largest modifiable risk factor for dementia, and cardiovascular risk factors may contribute to cochlear microvascular disease [3].
- **Avoid ototoxic substances:** Limit exposure to known ototoxic chemicals (solvents, heavy metals) in occupational settings. Wear appropriate protective equipment.
- **Regular exercise:** Moderate physical activity may improve cochlear blood flow and has been associated with better hearing outcomes in observational studies.
### Nutritional Considerations
- Some studies suggest that diets rich in omega-3 fatty acids, folate, and antioxidants may be associated with a lower risk of age-related hearing loss, though evidence remains preliminary and supplementation is not currently recommended as a treatment.
## OTC Medications That Help
It is important to note that **no OTC medication can reverse sensorineural hearing loss**. OTC options are limited primarily to treating reversible causes (e.g., wax impaction, eustachian tube congestion) or managing associated symptoms.
| Class | Example | Adult Dose | Notes |
|---|---|---|---|
| Cerumenolytics | Carbamide peroxide 6.5% (Debrox) | 5–10 drops in affected ear twice daily for up to 4 days | Softens earwax; do not use with ear tubes, perforated eardrum, or ear drainage |
| Cerumenolytics | Mineral oil or glycerin drops | 2–3 drops in affected ear at bedtime | Gentle softening agent; safe for most adults |
| Nasal decongestants | Pseudoephedrine 30–60 mg | Every 4–6 hours (max 240 mg/day) | May relieve eustachian tube congestion contributing to conductive hearing loss; avoid in uncontrolled hypertension, glaucoma, or with MAOIs |
| Topical nasal decongestants | Oxymetazoline 0.05% spray (Afrin) | 2–3 sprays per nostril every 12 hours | For short-term eustachian tube relief (max 3 days to avoid rebound congestion) |
| Nasal corticosteroid sprays | Fluticasone propionate (Flonase) | 1–2 sprays per nostril once daily | May reduce nasal/eustachian tube inflammation in allergic rhinitis–associated hearing fullness; onset of full effect in days to weeks |
| Oral antihistamines | Cetirizine 10 mg or loratadine 10 mg | Once daily | May help if allergic rhinitis is contributing to eustachian tube dysfunction; generally non-sedating |
| Analgesics | Ibuprofen 200–400 mg or acetaminophen 500–1000 mg | Every 4–6 hours as needed | For ear pain associated with acute otitis media or other inflammatory causes; note that chronic high-dose NSAID use may itself be ototoxic |
| OTC hearing amplifiers (PSAPs) | Various brands | N/A — device, not medication | Not FDA-regulated hearing aids but may provide mild amplification; not a substitute for professional evaluation |
| OTC hearing aids | Various (FDA class since 2022) | N/A — device | Available since October 2022 for adults with perceived mild-to-moderate hearing loss; no prescription needed |
> **Note:** The FDA finalized a rule in August 2022 establishing OTC hearing aids as a new regulatory category, making them available without a prescription, audiological exam, or medical evaluation for adults 18 and older with perceived mild-to-moderate hearing loss [7].
## Prescription Options
Prescription treatments for hearing loss depend on the underlying cause and type. Below are the main categories:
| Class | Examples | Indication | Prescriber |
|---|---|---|---|
| **Systemic corticosteroids** | Prednisone 60 mg/day × 10–14 days (tapered) | Sudden sensorineural hearing loss (SSNHL); autoimmune inner ear disease | ENT specialist, emergency physician |
| **Intratympanic corticosteroids** | Dexamethasone 10–24 mg/mL or methylprednisolone 40 mg/mL injected through the tympanic membrane | SSNHL (primary or salvage therapy); Ménière's disease | ENT specialist |
| **Antibiotics (oral)** | Amoxicillin 500 mg TID × 7–10 days; amoxicillin-clavulanate | Acute otitis media with hearing loss | Primary care, ENT |
| **Antibiotics (topical otic)** | Ciprofloxacin/dexamethasone otic drops | Otitis externa with canal edema causing hearing loss | Primary care, ENT |
| **Antivirals** | Valacyclovir 1 g TID × 7 days | SSNHL if viral etiology suspected (e.g., herpes); Ramsay Hunt syndrome | ENT specialist |
| **Diuretics** | Hydrochlorothiazide 25–50 mg daily | Ménière's disease (reduce endolymphatic hydrops) | ENT specialist, primary care |
| **Betahistine** | Betahistine 16 mg TID | Ménière's disease (available outside the US) | ENT specialist |
| **Immunosuppressants** | Methotrexate, cyclophosphamide | Autoimmune inner ear disease refractory to steroids | Rheumatologist, ENT |
| **Prescription hearing aids** | Custom-fit digital devices | Moderate-to-severe hearing loss | Audiologist, ENT |
| **Cochlear implants** | Surgical device | Severe-to-profound SNHL not adequately helped by hearing aids | ENT/otologist surgeon |
| **Bone-anchored hearing systems** | BAHA, Osia | Conductive or mixed hearing loss; single-sided deafness | ENT surgeon |
| **Surgical interventions** | Stapedectomy, tympanoplasty, myringotomy with tubes | Otosclerosis, chronic otitis media, middle ear effusion | ENT surgeon |
### Key Prescribing Considerations
- **SSNHL:** The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) 2019 guideline recommends offering oral and/or intratympanic corticosteroids within 2 weeks of symptom onset, with intratympanic steroids as an option for initial or salvage therapy [6].
- **Hearing aids** remain the mainstay of management for most patients with permanent mild-to-moderate SNHL. A Cochrane review has confirmed their benefit for speech perception and quality of life.
- **Cochlear implants** are recommended for adults with severe-to-profound bilateral SNHL who receive limited benefit from hearing aids. Candidacy criteria have expanded in recent years.
## Lab Tests Typically Ordered
The workup for hearing loss varies by presentation. Below are commonly ordered tests:
| Test | Rationale |
|---|---|
| **Pure-tone audiometry** | Gold standard for quantifying hearing loss type (conductive vs. sensorineural), severity, and configuration; performed by an audiologist |
| **Tympanometry** | Assesses middle ear function, tympanic membrane compliance, and middle ear pressure — helps identify effusions, perforations, and ossicular chain problems |
| **Speech audiometry (SRT/WRS)** | Measures speech reception threshold and word recognition score, which guide hearing aid candidacy and surgical decisions |
| **Otoacoustic emissions (OAEs)** | Tests outer hair cell function; useful for newborn screening and differentiating cochlear from retrocochlear pathology |
| **Auditory brainstem response (ABR)** | Evaluates auditory nerve and brainstem pathway integrity; used for newborn screening and when acoustic neuroma is suspected |
| **MRI of internal auditory canals with gadolinium** | Indicated for asymmetric SNHL or unilateral tinnitus to rule out vestibular schwannoma (acoustic neuroma) [6] |
| **CT of temporal bones** | Evaluates bony anatomy; useful in trauma, cholesteatoma, otosclerosis, and congenital malformations |
| **Complete blood count (CBC)** | May help identify infection or hematologic abnormalities contributing to hearing loss |
| **Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)** | Inflammatory markers; elevated in autoimmune inner ear disease or vasculitis |
| **Thyroid function tests (TSH, free T4)** | Hypothyroidism is associated with sensorineural hearing loss; screening may be warranted |
| **Fasting glucose / HbA1c** | Diabetes mellitus is associated with an increased risk of hearing loss; microvascular disease may affect cochlear blood supply |
| **Syphilis serology (RPR/VDRL, FTA-ABS)** | Congenital or tertiary syphilis can cause sensorineural hearing loss |
| **Autoimmune panel (ANA, anti-dsDNA, anti-68kD antibody)** | When autoimmune inner ear disease is suspected, particularly with bilateral rapidly progressive SNHL |
| **Lyme serology** | In endemic areas, Lyme disease can cause cranial neuropathy including hearing loss |
## Special Populations
### Children
- Hearing loss affects approximately 1–3 per 1,000 newborns and is a leading cause of speech and language delay. Universal newborn hearing screening is mandated in most US states.
- **Otitis media with effusion** is the most common cause of hearing loss in children. The AAO-HNS guideline recommends watchful waiting for 3 months in uncomplicated cases, with myringotomy and tube placement for persistent effusion with hearing loss [5].
- Pediatric hearing aid fitting and cochlear implant candidacy require specialized pediatric audiology assessment. The FDA has approved cochlear implants for children as young as 9 months.
- **Aminoglycoside ototoxicity** requires careful dose monitoring in neonates and children. Pediatric dosing should always be weight-based and determined by a pediatrician or pharmacist.
- **Do not use OTC hearing aids in children** — they are approved only for adults aged 18+.
- Genetic causes account for approximately 50–60% of congenital hearing loss; genetic counseling and testing (e.g., connexin 26/GJB2 mutation) may be recommended.
### Pregnancy
- Otosclerosis may worsen during pregnancy due to hormonal changes, and some women first notice hearing loss during this time.
- **Systemic corticosteroids** (e.g., prednisone) are generally considered compatible with pregnancy when clinically necessary (former FDA Category C), but risks and benefits should be carefully discussed with the obstetrician.
- **Intratympanic steroids** may be preferred in pregnancy for SSNHL, as systemic absorption is minimal.
- **Aminoglycoside antibiotics** should be avoided in pregnancy due to risk of fetal ototoxicity.
- MRI without gadolinium is generally considered safe in pregnancy for evaluating concerning hearing loss, but gadolinium contrast should be avoided unless absolutely necessary.
### Elderly
- Presbycusis is nearly universal in advanced age. The Lancet Commission on Dementia identified hearing loss as the largest potentially modifiable risk factor for dementia, accounting for up to 8% of cases [3].
- Hearing aid uptake remains low — only about 20% of adults who could benefit from hearing aids actually use them. Barriers include cost, stigma, and difficulty with device management [2].
- The 2022 FDA rule on OTC hearing aids may improve access for older adults with mild-to-moderate loss [7].
- Cerumen impaction is particularly common in elderly populations and should be regularly assessed, especially in nursing home residents.
- Polypharmacy increases the risk of ototoxic drug exposure; medication review is important.
- Cognitive screening should be considered in elderly patients presenting with hearing loss, given the strong association with dementia.
- Dual sensory loss (hearing and vision) in the elderly significantly increases fall risk and social isolation.
### Athletes
- **Barotrauma** is a concern for divers and swimmers. Middle ear barotrauma ("ear squeeze") can cause conductive hearing loss, tympanic membrane rupture, or in severe cases, perilymphatic fistula with sensorineural loss.
- **Noise exposure** from firearms (shooting sports) is a major cause of NIHL in athletes. Custom-fitted hearing protection is recommended.
- Swimmers should keep ears dry to prevent otitis externa, which can cause temporary conductive hearing loss. Alcohol-based drying drops after swimming may help.
- **Contact sports** carry risk of temporal bone fracture and tympanic membrane perforation from direct blows to the ear. Headgear is recommended where applicable.
- Athletes with single-sided deafness should consider protective headgear for the hearing ear during contact sports.
## When to Escalate
Use the following thresholds to determine the appropriate level of care:
### Call 911 or Go to the ER Immediately
- Sudden hearing loss following head trauma, especially with bleeding from the ear, clear fluid drainage, or altered consciousness
- Hearing loss with signs of stroke (facial droop, arm weakness, speech difficulty)
- Hearing loss with high fever, severe headache, and neck stiffness (concern for meningitis)
- Hearing loss with severe vertigo and inability to stand or walk
### Same-Day / Urgent ENT Referral
- **Sudden sensorineural hearing loss** (rapid onset over hours to 3 days) — treatment with corticosteroids should ideally begin within 72 hours. Every day of delay may reduce the chance of recovery [6]
- Hearing loss with facial nerve paralysis
- Hearing loss with bloody or purulent ear discharge not responding to initial treatment
### See Your GP Within 1–2 Weeks
- Gradual hearing loss noticed over weeks to months
- Hearing loss with persistent ear fullness, tinnitus, or mild balance issues
- Hearing difficulty affecting work, social interactions, or safety
- Suspected medication-related hearing loss (do not stop prescribed medications without medical guidance)
### Routine Audiology Referral
- Age-related hearing difficulty affecting communication
- Interest in hearing aids or assistive listening devices
- Follow-up audiometry for known stable hearing loss
- Occupational hearing conservation screening
> **General guideline:** If you are unsure whether your hearing loss requires urgent attention, err on the side of caution and seek same-day medical evaluation. Sudden hearing loss in particular is a time-sensitive emergency where early treatment significantly improves outcomes.
## References
[1] World Health Organization. World Report on Hearing. Geneva: WHO; 2021. Available at: https://www.who.int/publications/i/item/world-report-on-hearing
[2] Cunningham LL, Tucci DL. Hearing Loss in Adults. N Engl J Med. 2017;377(25):2465-2473. PMID:29262274
[3] Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446. PMID:32738937
[4] Gates GA, Mills JH. Presbycusis. Lancet. 2005;366(9491):1111-1120. PMID:16182900
[5] Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol Head Neck Surg. 2016;154(1 Suppl):S1-S41. PMID:26832942
[6] Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1-S45. PMID:31369359
[7] U.S. Food and Drug Administration. FDA Finalizes Historic Rule Enabling Access to Over-the-Counter Hearing Aids for Millions of Americans. August 16, 2022. Available at: https://www.fda.gov/news-events/press-announcements/fda-finalizes-historic-rule-enabling-access-over-counter-hearing-aids-millions-americans
[8] Lin FR, Metter EJ, O'Brien RJ, Resnick SM, Zonderman AB, Ferrucci L. Hearing loss and incident dementia. Arch Neurol. 2011;68(2):214-220. PMID:21320988
[9] National Institute for Health and Care Excellence (NICE). Hearing loss in adults: assessment and management. NICE guideline [NG98]. Published June 2018. Available at: https://www.nice.org.uk/guidance/ng98
[10] Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ. 2014;92(5):367-373. PMID:24839326
---
*This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of hearing loss or any medical condition.*
PillsCard
Loading PillsCard…
Loading the latest data0%